CLINICAL_TRIALS ClinicalTrials.gov record with results posted

Open-label Study of Androgen Receptor Inhibition With dArolutamide Plus Androgen Deprivation Therapy (ADT) Versus ADT in Men With Metastatic Hormone-Sensitive Prostate Cancer Using an External Control Arm

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05059236
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-09-16T00:02:05.613664+00:00
Published At: 2026-09-15T00:00:00+00:00
Record Updated At: 2026-09-15
Results Posted At: 2026-09-15
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Metastatic Hormone-sensitive Prostate Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2026-09-15"
protocolSection.identificationModule.nctId: "NCT05059236"
protocolSection.identificationModule.officialTitle: "Open-label Study of Androgen Receptor Inhibition With dArolutamide Plus Androgen Deprivation Therapy (ADT) Versus ADT in Men With Metastatic Hormone-Sensitive Prostate Cancer Using an External Control Arm"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2026-09-15"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.